Pregnancy: Sustained-release capsule: Do not take if pregnant unless recommended by physician.
Syrup: Caution is advised when ambroxol is used during pregnancy. Use during the first trimester of pregnancy is not recommended. Ambroxol crosses placenta. Animal studies do not show either a direct or indirect harmful effect on pregnancy, embryofoetal development, parturition or postnatal development. Comprehensive controlled studies in pregnant women after the 28th week have not shown any harmful effects on the foetus.
Lactation: Sustained-release capsule: Do not take if breastfeeding unless recommended by physician.
Syrup: Ambroxol is excreted in breast milk and should not be taken during lactation. However, no adverse effects on the breastfed infants are expected.
Other Services
Country
Support
Account
Sign Out